HS-10376

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10376, covering 2022-06-28 to 2022-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]